UNSPSC 51442707: Technetium Tc-99m gluceptate or technetium 99mtc gluceptate

This classification denotes a radioconjugate, an contrast medium is study ntracranial lesions, cerebral disorders, and renal disorders, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I853LE095B. The European Medicines Agency schedules Technetium tc 99m gluceptate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15469MIG. Technetium Tc 99m gluceptate generally arises in the molecular formula C7H14O8.TC. The term 'Technetium Tc-99m gluceptate' is a U.S. FDA Orange Book designation.

Most nations schedule Technetium Tc-99m gluceptate or technetium 99mtc gluceptate under HS 28444030.

UNSPSC 51442707 Technetium Tc-99m gluceptate or technetium 99mtc gluceptate is a Commodity code that nominally covers radiopharmaceutical products, but recent state and local solicitations tagged under this code show minimal alignment with the code's actual scope. The two most recent opportunities posted under this code involve X-ray system maintenance services (Broward County Aviation Department) and chemical supply (Pasco County copper sulfate procurement), neither of which relates to technetium gluceptate products. State and local procurement activity under this code appears sparse and misaligned with the code's intended product category.

No representative state and local opportunities for technetium gluceptate or related radiopharmaceutical imaging agents are present in the recent solicitation record. The code shows little relevant recent activity, suggesting either minimal demand for this specific pharmaceutical product at the state and local level or systematic miscoding of unrelated commodities. Business development professionals evaluating this code should verify whether state and local health systems, imaging centers, or hospital purchasing consortia are actively procuring under it, as the current record does not support targeted pursuit.